At Trias Pharma, we specialize in providing hands-on, expert CMC support for advanced drug products—from concept to submission. Our expertise spans tablets, hard capsules, softgel capsules, medicinal cannabis, and analytical development. We bring years of experience and employ a systematic approach to overcome challenges in drug product development.

Backed by profound knowledge of excipients, equipment, processes, and documentation, we assist clients in comprehending critical factors and developing robust dosage forms. Beyond solid dosage forms like soft capsules and tablets, our proficiency extends to advanced delivery systems for the oral route, pulmonary applications, and local applications.

Drawing from a strong CDMO background, we augment technological aspects with insights into commercial, contractual, and intellectual property topics.
Why work with us?

✅ Comprehensive approach to CMC activities
We address all aspects of solid dosage forms development, from formulation to regulatory documentation applying a structured, systematic approach.

✅ We understand complex products
With a solid technological background, we design development programs to reach a profound understanding of critical factors. Considering ICH Q8 requirements, we apply a systematic and risk-based approach to formulation and process development.

✅ Core expertise in advanced solid formulations
We bring outstanding technical expertise in soft capsules, and single and multiple-unit solid drug delivery systems for the efficient development of advanced drug products.

Trias Pharma GmbH

Org chart

Teams

Offices